Video

Transitions of Care and Patient Follow-Up

Michael A. Evans, BS, RPh, describes why patient follow-up is necessary during transitions of care scenarios following the initiation of treatment with an anticoagulant. Warfarin therapy requires close, regular monitoring by a patient’s healthcare team; thus, the management of patients taking warfarin can be a challenge, especially during transitions of care, notes Mr Evans. In contrast, he adds, the management of patients taking direct-acting oral anticoagulants is comparatively easier, as these agents do not require routine monitoring.

Regardless of which treatment option is prescribed for a patient, patient follow-up is important during transitions of care scenarios because it can help prevent drug-related adverse events and thromboembolic complications, says Mr Evans. Patients and their caregivers need to be educated about the purpose of their treatment, the potential for side effects and drug-drug interactions, and the importance of taking their treatment as prescribed. The nature and frequency of follow-up care should be individualized following an assessment by a clinician, he suggests.

Institutions should establish protocols for appropriate follow-up care, which includes follow-up phone calls. The individual that makes the follow-up phone calls with the patient following a transition of care need not be the physician. Rather, any member of a patient’s multidisciplinary care team (eg, a nurse, pharmacist, assistant) can make follow-up phone calls.


Related Videos
Corey McEwen, PharmD, MS
Kirollos Hanna, PharmD
Jessica Meyers, MSEd, and Amy Herschell PhD
Screenshot of an interview with A. Mark Fendrick, MD
dr jennifer green
dr ken cohen
dr ian neeland
dr manisha jhamb
dr ty gluckman
Brooke Kempf
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo